Picture of Barinthus Biotherapeutics logo

BRNS — Barinthus Biotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Vaccitech Reports Q1 Loss Per Share Of $1.90

June 14 (Reuters) - Vaccitech PLC  VACC.O :
    * VACCITECH REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND
RECENT CORPORATE DEVELOPMENTS
    * Q1 LOSS PER SHARE $1.90
    * BELIEVES ITS CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO
FUND
OPERATIONS INTO 2024
    * GENERATED A NET LOSS OF $15.3 MILLION, OR $1.90 PER BASIC
AND
DILUTED SHARE, FOR Q1 OF 2021

Source text for Eikon:  ID:nGNX2fBK52 
Further company coverage:  VACC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Barinthus Biotherapeutics

See all news